Sub-10¢ Watch: 10 Stocks That Could Explode — August 24, 2026

Introduction Investors often overlook stocks priced under 10 cents, yet these low-float, low-price equities can offer explosive returns. With careful analysis, these stocks could provide significant upside potential in a volatile market. Below are ten stocks in this price range that could explode in the coming months.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.08 - **Sector**: Cannabis - **Volume Profile**: Recent trading sessions show increasing volume, indicating accumulation. - **Short Interest**: Approximately 15% of float, suggesting potential for a short squeeze. - **Catalyst**: Regulatory changes in Canada and potential U.S. market expansion could act as key drivers. - **Technical Setup**: The stock is bouncing off a support level at $0.07. - **Risk Factors**: Regulatory hurdles and market competition. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

2. MVIS - MicroVision, Inc. - **Current Price**: $0.09 - **Sector**: Technology - **Volume Profile**: Volume has spiked recently, indicating strong buying interest. - **Short Interest**: Short interest stands at around 20%. - **Catalyst**: Upcoming product launches and partnerships in the LiDAR space. - **Technical Setup**: The stock is breaking out of a consolidation phase. - **Risk Factors**: Execution risk in product development and competition. - **Bull Case Price Target**: $0.20 (30-90 days) - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.07 - **Sector**: Health Insurance - **Volume Profile**: Increased volume suggests accumulation by investors. - **Short Interest**: Approximately 25% short interest indicates a possible squeeze. - **Catalyst**: Potential partnerships and expansion of insurance offerings. - **Technical Setup**: The stock is testing a support level at $0.06. - **Risk Factors**: Regulatory issues and competition in the healthcare sector. - **Bull Case Price Target**: $0.12 (30-90 days) - **Risk Rating**: 🟡 High

4. AITX - Artificial Intelligence Technology Solutions, Inc. - **Current Price**: $0.05 - **Sector**: Technology - **Volume Profile**: Significant increase in volume suggests growing interest. - **Short Interest**: Around 10% of the float is shorted. - **Catalyst**: New product announcements and potential contracts in security solutions. - **Technical Setup**: Recently bounced off a support level at $0.04. - **Risk Factors**: High burn rate and competition in the AI space. - **Bull Case Price Target**: $0.10 (30-90 days) - **Risk Rating**: 🟡 High

5. ZOM - Zomedica Corp. - **Current Price**: $0.09 - **Sector**: Veterinary Health - **Volume Profile**: Accumulation is evident with rising volume. - **Short Interest**: Approximately 18% short interest. - **Catalyst**: Product launches for veterinary diagnostics. - **Technical Setup**: Testing a key support level at $0.08. - **Risk Factors**: Product adoption rates and financial stability. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

6. GFAI - Guardforce AI Co., Limited - **Current Price**: $0.06 - **Sector**: Security Technology - **Volume Profile**: Increased trading volume shows accumulation. - **Short Interest**: Short interest is about 12%. - **Catalyst**: Expanding international contracts could drive demand. - **Technical Setup**: The stock is consolidating above $0.05 support. - **Risk Factors**: Dependence on contract wins and cash flow issues. - **Bull Case Price Target**: $0.10 (30-90 days) - **Risk Rating**: 🟡 High

7. HTGM - HTG Molecular Diagnostics, Inc. - **Current Price**: $0.08 - **Sector**: Biotechnology - **Volume Profile**: Rising volume indicates accumulation. - **Short Interest**: Approximately 22% short interest. - **Catalyst**: Potential FDA approvals for diagnostic tests. - **Technical Setup**: The stock is on an upward trajectory from support at $0.07. - **Risk Factors**: Regulatory hurdles and cash burn. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

8. VUZI - Vuzix Corporation - **Current Price**: $0.09 - **Sector**: Augmented Reality - **Volume Profile**: Increasing volume suggests strong market interest. - **Short Interest**: Approximately 15% short interest. - **Catalyst**: New product launches and partnerships in the AR space. - **Technical Setup**: Recently broke above $0.08 resistance. - **Risk Factors**: Rapid technological changes and competition. - **Bull Case Price Target**: $0.20 (30-90 days) - **Risk Rating**: 🟡 High

9. NAKD - Naked Brand Group Limited - **Current Price**: $0.06 - **Sector**: Apparel - **Volume Profile**: Volume spikes suggest accumulation. - **Short Interest**: Approximately 30% of shares are shorted. - **Catalyst**: Potential turnaround strategies and partnerships. - **Technical Setup**: Testing support at $0.05. - **Risk Factors**: Market competition and execution risk. - **Bull Case Price Target**: $0.10 (30-90 days) - **Risk Rating**: 🟡 High

10. CHNR - China Natural Resources, Inc. - **Current Price**: $0.09 - **Sector**: Natural Resources - **Volume Profile**: Recent volume increases indicate buying interest. - **Short Interest**: Short interest is around 10%. - **Catalyst**: Potential resource discovery announcements. - **Technical Setup**: The stock is bouncing off a critical support level at $0.08. - **Risk Factors**: Commodity price fluctuations and geopolitical risks. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-priced stocks often have a lower market capitalization, which can lead to increased volatility. The mechanical advantages include the potential for significant percentage gains on small price movements and the ability to attract retail investors seeking low entry points. However, this volatility also means that losses can accumulate quickly.

How to Trade Them Safely Investors should employ strict risk management strategies when trading low-priced stocks. Position sizing is crucial; limit orders should be used to avoid significant slippage. Timing around catalysts can also be important—investors should remain aware of upcoming announcements that could affect stock prices.

Catalyst Calendar - **SNDL**: Potential regulatory announcements in Q3 2026. - **MVIS**: New product launch expected in September 2026. - **CLOV**: Earnings report due in late August 2026. - **AITX**: Contract announcements expected in October 2026. - **ZOM**: FDA approval expected in Q4 2026.

Educational content only. Not financial advice. DYOR.